ChromoTek CTLA4 VHH, recombinant binding protein for 2x Cys conjugation
Alpaca anti-CTLA4 VHH, purified recombinant binding protein. Suitable for for cysteine conjugation with thiol-reactive reagents, e.g. maleimides. Note: unconjugated VHHs are not suited for usage without prior labeling, since they contain reactive Cysteines. Shipment and storage buffers contain TCEP to keep Cysteins reduced.
Cat no : ctlCys2
Synonyms
Validation Data Gallery
Product Information
Alpaca anti-CTLA4 VHH, purified recombinant binding protein. Suitable for for cysteine conjugation with thiol-reactive reagents, e.g. maleimides. Note: unconjugated VHHs are not suited for usage without prior labeling, since they contain reactive Cysteines. Shipment and storage buffers contain TCEP to keep Cysteins reduced.
Applications | Conjugation |
Reactivity | Human |
Conjugate | Unconjugated |
Type | Nanobody |
Class | Recombinant |
Host | Alpaca |
Affinity | 22 nM |
Molecular Weight | 14.005 kDa |
Form | Liquid |
RRID | AB_3101936 |
Storage Buffer | 10 mM HEPES, 500 mM NaCl, pH 7.0, 1 mM TCEP, 0.09% sodium azide |
Storage Condition | Store at -20°C |
Background | CTLA-4, also known as CD152, belonging to the immunoglobulin superfamily, is primarily found on activated T cells and regulatory T cells (Tregs). CTLA-4 is closely related to the T-cell costimulatory CD28, and both molecules bind to B7-1 and B7-2 on antigen-presenting cells. CTLA-4 acts as a negative regulatory molecule of T-cell responses. Besides the full-length transmembrane form, CTLA-4 also exists in a truncated soluble form (sCTLA-4). |
Documentation
SDS |
---|
SDS-Immuno-Oncology VHHs |